Lv1
40 积分 2025-03-07 加入
Safety and preliminary efficacy of puxitatug samrotecan (AZD8205) in patients with endometrial cancer: A first-in-human phase I/IIa study
1个月前
已完结
EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer
3个月前
已完结
APC mutations as a predictive marker of endometrial cancer immunotherapy: a retrospective cohort study
4个月前
已完结
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes
6个月前
已完结
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
6个月前
已完结
皖公网安备34019202002308
